logo image

HIV Molecular Immunology Database

Search Antibody Database

Found 1 matching record:

Displaying record number 1054

Download this epitope record as JSON.

MAb ID 39H10/A11
HXB2 Location Env Env Epitope Map
Author Location gp120(gp120 SF162)
Research Contact Dr. Abraham Pinter, Public Health Research Institute, Newark, NJ, pinter@phri.org
Epitope
Subtype B
Ab Type  
Neutralizing no
Species (Isotype) transgenic mouse(IgG2κ)
Patient  
Immunogen vaccine
Keywords antibody interactions, binding affinity

Vaccine Details

Vaccine type protein
Vaccine strain B clade SF162
Vaccine component gp120
Adjuvant Ribi adjuvant (MPL+TDM) (RIBI)

Notes

Showing 2 of 2 notes.

References

Showing 2 of 2 references.

He2002 Yuxian He, William J. Honnen, Chavdar P. Krachmarov, Michael Burkhart, Samuel C. Kayman, Jose Corvalan, and Abraham Pinter. Efficient Isolation of Novel Human Monoclonal Antibodies with Neutralizing Activity Against HIV-1 from Transgenic Mice Expressing Human Ig Loci. J. Immunol., 169(1):595-605, 1 Jul 2002. PubMed ID: 12077293. Show all entries for this paper.

Tuen2005 Michael Tuen, Maria Luisa Visciano, Peter C. Chien, Jr., Sandra Cohen, Pei-de Chen, James Robinson, Yuxian He, Abraham Pinter, Miroslaw K Gorny, and Catarina E Hioe. Characterization of Antibodies that Inhibit HIV gp120 Antigen Processing and Presentation. Eur. J. Immunol., 35(9):2541-2551, Sep 2005. PubMed ID: 16106369. Show all entries for this paper.


This is a legacy search page. It is deprecated, will receive no more updates, and will eventually be removed. Please use the new search pages.

Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy's National Nuclear Security Administration
Copyright Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services LANL logo National Institutes of Health logo